You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API revefenacin

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing revefenacin

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Mylan Specialty LP	YUPELRI	revefenacin	49502-806	CITRIC ACID MONOHYDRATE	2031-08-25
Mylan Specialty LP	YUPELRI	revefenacin	49502-806	HYDROCHLORIC ACID	2031-08-25
Mylan Specialty LP	YUPELRI	revefenacin	49502-806	SODIUM CHLORIDE	2031-08-25
Mylan Specialty LP	YUPELRI	revefenacin	49502-806	SODIUM HYDROXIDE	2031-08-25
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for revefenacin

Excipient focus: CITRIC ACID MONOHYDRATE

revefenacin drug variants containing CITRIC ACID MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Mylan Specialty LP	revefenacin	49502-806
>Company	>Ingredient	>NDC

revefenacin drug variants not containing CITRIC ACID MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

revefenacin drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Mylan Specialty LP	revefenacin	49502-806
>Company	>Ingredient	>NDC

revefenacin drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

revefenacin drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Mylan Specialty LP	revefenacin	49502-806
>Company	>Ingredient	>NDC

revefenacin drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

revefenacin drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Mylan Specialty LP	revefenacin	49502-806
>Company	>Ingredient	>NDC

revefenacin drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRISODIUM CITRATE DIHYDRATE

revefenacin drug variants containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Mylan Specialty LP	revefenacin	49502-806
>Company	>Ingredient	>NDC

revefenacin drug variants not containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

revefenacin drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Mylan Specialty LP	revefenacin	49502-806
>Company	>Ingredient	>NDC

revefenacin drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.